Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.
about
Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cellsAndrogen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancerSRC: marker or actor in prostate cancer aggressivenessThe endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a cxcl signaling module.Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate CancerThe CXCL8-CXCR1/2 pathways in cancerExtracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironmentUnique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cellsConstitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancerKey roles of necroptotic factors in promoting tumor growthRunx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistanceRegulation of DNA synthesis and the cell cycle in human prostate cancer cells and lymphocytes by ovine uterine serpin.Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progressionPropionibacterium acnes infection induces upregulation of inflammatory genes and cytokine secretion in prostate epithelial cellsLow vitamin D status is associated with inflammation in patients with prostate cancerCombined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness.Withania somnifera targets interleukin-8 and cyclooxygenase-2 in human prostate cancer progression.Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival.The role of chemoattractant receptors in shaping the tumor microenvironment.Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and ProgressionInverse relationship between PSA and IL-8 in prostate cancer: an insight into a NF-κB-mediated mechanism.Targeting IL-8 in colorectal cancer.Dysfunctional activation of neurotensin/IL-8 pathway in hepatocellular carcinoma is associated with increased inflammatory response in microenvironment, more epithelial mesenchymal transition in cancer and worse prognosis in patientsTargeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer.Haplotypes in IL-8 Gene Are Associated to Age-Related Macular Degeneration: A Case-Control Study.Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer.IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.Androgen receptor signaling in prostate cancer development and progression.Vitamin d, sunlight and prostate cancer riskThe functional role of reactive stroma in benign prostatic hyperplasia.Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer.P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 PathwayThe CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptorMonocyte-Induced Prostate Cancer Cell Invasion is Mediated by Chemokine ligand 2 and Nuclear Factor-κB ActivityTR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals.Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer.As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signalingThe role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma
P2860
Q21132994-259D3854-C4F1-4E7D-8E1A-2267E5F5E383Q21136183-B4DAECA7-DD9C-4DDC-81D6-EA8D0E5350B4Q27012541-B21E0361-AB07-419B-8A57-A8923ED440E9Q27348356-703A79E7-FFD5-438C-8D8F-EAD513FFD27FQ28075965-C5EC3CA8-AFA7-4C9F-A91B-777DFE74CFA7Q28075994-976D7802-1F97-4F38-A932-CD7625A31A86Q28304032-A118ABB1-FA7D-4548-8AF9-1A2CA2C7124EQ28391298-CD532729-C3B5-4F50-A88F-BF2960104B4AQ28483606-0A4C319C-FCC0-474A-B458-5D4E315CEDB6Q28828140-D8CF784C-2209-4F6F-B0A7-EC70712B4D96Q30435146-09133995-5B10-4B2B-BED9-22BCC456FBA8Q30500080-D3284FC1-DDD7-49C9-97E5-7383EEC9DA44Q33316414-F98D453B-8C31-4A96-BA1F-72C0BB69A4EBQ33520381-A9ED00FB-A7B3-4F66-8EF4-46D6CD0C8D5EQ33564953-8E7C3B70-202F-4B8B-BF12-582D15568D54Q33591811-67EA4B6C-287F-4499-B426-D1689F25191DQ33602017-B04CBA0D-B576-42D5-A056-0C91D84EA8ACQ33739134-B15F8B94-A11D-43A3-A638-7365C3A54B2BQ33763973-39DB834F-8783-4CA5-BCBC-838A5C434039Q33780482-DA603272-3F8D-4BAD-BABB-5A588614B6BDQ33993124-D029EDFF-E03C-4089-800D-230B0F17767FQ34090617-4165CABC-39D3-4A20-9B29-920C6590DB4DQ34189747-30EC1D39-9B05-4804-B555-E043854BFA7FQ34267408-692615D1-448F-41FA-B5C3-EB8824C4D820Q34589814-3CB689DA-893E-43E0-9B12-8347E1D1FCCCQ34646050-CC413E58-31AD-402C-8611-28EFD3295DC8Q34806228-CA7CA73B-499C-4250-AD22-9A4A9949AB8EQ35044351-A371243F-14E4-4D14-AF34-74B2E7E74A12Q35134651-4443CE0B-7E88-49CE-ABE7-1D4471D19CB4Q35183663-18C4D6CD-B2B3-4A99-BC44-5394B15E49EAQ35207472-EC3328DB-8853-4AA1-90A3-36415C172EF1Q35231687-3E225986-8370-4A18-875F-C639513E8260Q35641782-1ACBB82C-AED8-4476-B0BB-C41AEDC693EFQ35693663-3621979A-CE76-4D20-B812-5DA37B2245C0Q35838409-E7922446-C1D1-40BB-BA6D-CD92BCCE831DQ35994680-98DFBE84-47E4-42FE-BD53-3261F08D4130Q36021034-D067959C-A5F2-4B32-BC98-462982373DB4Q36084010-541AD0DE-2E2C-4762-B1CE-CBB40C80F9F5Q36118892-E102052B-28BB-40CE-9E2A-A507C8C2252EQ36544635-5BB87EB9-FFA9-4191-AF8B-50D30424B29A
P2860
Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Interleukin-8 is a molecular d ...... rogression in prostate cancer.
@en
type
label
Interleukin-8 is a molecular d ...... rogression in prostate cancer.
@en
prefLabel
Interleukin-8 is a molecular d ...... rogression in prostate cancer.
@en
P2093
P1433
P1476
Interleukin-8 is a molecular d ...... rogression in prostate cancer.
@en
P2093
Bal L Lokeshwar
David M Meinbach
Dominic Lyn
Rajendra K Singh
Shinako Araki
Vinata B Lokeshwar
Yekutiel Sandman
Yohei Omori
P304
P356
10.1158/0008-5472.CAN-07-1162
P407
P577
2007-07-01T00:00:00Z